Literature DB >> 10521704

Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme.

K Katayama1, N Ueda, I Katoh, S Yamamoto.   

Abstract

Anandamide, an endogenous ligand for cannabinoid receptors, loses its biological activities when it is hydrolyzed to arachidonic acid and ethanolamine by anandamide amidohydrolase. We overexpressed a recombinant rat enzyme with a hexahistidine tag in a baculovirus-insect cell expression system, and purified the enzyme with the aid of a Ni-charged resin to a specific activity as high as 5.7 micromol/min/mg protein. The purified recombinant enzyme catalyzed not only the hydrolysis of anandamide and palmitoylethanolamide, but also their reverse synthetic reactions. In order to attain an equilibrium of the anandamide hydrolysis and its reverse reaction within 10 min, we utilized a large amount of the purified enzyme. The equilibrium constant ([arachidonic acid][ethanolamine])/([anandamide][water]) was calculated as 4x10(-3) (37 degrees C, pH 9.0). These experimental results with a purified enzyme preparation quantitatively confirmed the reversibility of the enzyme reaction previously observed with crude enzyme preparations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521704     DOI: 10.1016/s1388-1981(99)00124-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

2.  Unique pathway for anandamide synthesis and liver regeneration.

Authors:  Angelo A Izzo; Dale G Deutsch
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-13       Impact factor: 11.205

3.  Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain.

Authors:  Richard P Bazinet; Ho-Joo Lee; Christian C Felder; Amy C Porter; Stanley I Rapoport; Thad A Rosenberger
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

4.  Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.

Authors:  V Di Marzo; D Melck; P Orlando; T Bisogno; O Zagoory; M Bifulco; Z Vogel; L De Petrocellis
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

5.  Synthesis of phenoxyacyl-ethanolamides and their effects on fatty acid amide hydrolase activity.

Authors:  Lionel Faure; Subbiah Nagarajan; Hyeondo Hwang; Christa L Montgomery; Bibi Rafeiza Khan; George John; Peter Koulen; Elison B Blancaflor; Kent D Chapman
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

6.  The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria.

Authors:  Jonathan Z Long; Katrin J Svensson; Leslie A Bateman; Hua Lin; Theodore Kamenecka; Isha A Lokurkar; Jesse Lou; Rajesh R Rao; Mi Ra Chang; Mark P Jedrychowski; Joao A Paulo; Steven P Gygi; Patrick R Griffin; Daniel K Nomura; Bruce M Spiegelman
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

7.  Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

Authors:  Balapal S Basavarajappa
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 8.  Critical enzymes involved in endocannabinoid metabolism.

Authors:  Balapal S Basavarajappa
Journal:  Protein Pept Lett       Date:  2007       Impact factor: 1.890

9.  Identification and recombinant expression of anandamide hydrolyzing enzyme from Dictyostelium discoideum.

Authors:  Dhamodharan Neelamegan; Ian C Schoenhofen; James C Richards; Andrew D Cox
Journal:  BMC Microbiol       Date:  2012-06-25       Impact factor: 3.605

Review 10.  Endocannabinoids and related N-acylethanolamines: biological activities and metabolism.

Authors:  Kazuhito Tsuboi; Toru Uyama; Yasuo Okamoto; Natsuo Ueda
Journal:  Inflamm Regen       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.